Abstract: The present invention concerns a solid, palatable composition and its preparation process which, relative to the total weight of the composition, comprises: 5 to 30%, preferably 8 to 20% by weight of at least one fat chosen from among a liquid oil, a fat, wax or mixture thereof, the liquid oil not to represent more than 8% by weight of the composition; 0.001 to 85% by weight of at least one active substance; and 20 to 95%, preferably 40 to 70% by weight of at least one palatable material, for use thereof as medicinal product, nutraceutical or food supplement, for oral administration to mammals, except man, in particular for domestic animals such as dogs, cats or horses. The said solid composition is obtained by mixing the components, vaporising the fats, calibrating the dry, fluid granular material and compressing the granular material in a stock cube press.
Abstract: Provided are polymers (e.g., polymeric materials), nanoparticles comprising one or more of the polymers, and compositions. A polymer may be in the form of a nanoparticle. A polymer can be linear or branched. A polymer includes one or more poly(ester urea) segment, optionally, one or more poly(urethane) segment, optionally, one or more diol segment, optionally, one or more poly(ethylene glycol) segment, and, optionally, one or more terminal/end group. A polymer (e.g., a polymeric material) may include a branching moiety. For example, a composition includes one or more polymer. In an example, polymers and nanoparticles can be used to deliver a drug (e.g., gambogic acid) to an individual (e.g, who has been diagnosed with or is suspected of having cancer and/or a viral infection).
Abstract: The invention relates to the separation of manure in fractions and the treatment of said fractions in order to retrieve useful components to produce manure-derived bioplastic and other manure-derived bioproducts. The invention further relates to a method for producing composite (bio)plastic, and to a method for producing fibre from regenerated manure-derived cellulose. The methods include the steps of: flocculation treatment and a filtration treatment; pulping the manure-derived solid fractions; acetylation of the manure-derived dissolving-grade cellulose pulp with acetic anhydride and a catalyst; extracting fermentable components from the different fractions of the manure to produce monocarboxylic acids for use in the monocarboxylic acid carrier solution. Furthermore methods are disclosed for forming composite bioplastics with resin binding agents; and for spinning yarn from cellulose pulp.
Abstract: Combination cellulose materials and methods of making and using these materials. The combination material includes a first cellulosic material and a second cellulosic material.
Abstract: The present invention is related to methods for lowering peroxide levels in sucrose acetate isobutyrate formulations and to composition used in and formed by such methods.
Type:
Grant
Filed:
August 15, 2019
Date of Patent:
August 10, 2021
Assignee:
Durect Corporation
Inventors:
Gunjan Junnarkar, Michael A. Desjardin, John P. Carr
Abstract: Compounds, compositions, and methods for treatment and/or prevention of at least one disease, disorder, and/or condition by inhibiting binding of an E-selectin to an E-selectin ligand are disclosed. For example, highly potent multimeric E-selectin antagonist are desorbed and pharmaceutical compositions comprising at least one of the same.
Type:
Grant
Filed:
October 6, 2017
Date of Patent:
July 27, 2021
Assignee:
GLYCOMIMETICS, INC.
Inventors:
John L. Magnani, John M. Peterson, Myung-Gi Baek
Abstract: The present invention is directed to compositions comprising topiramate and a sulfoalkyl ether cyclodextrin, and methods of making and using the same.
Abstract: A method for cleaving amide bonds, comprising: a) providing a molecule comprising an amide group; b) reacting the molecule comprising an amide group with hydroxylamine (NH2OH) or a salt thereof to cleave the amide bond of the amide group.
Abstract: The present invention provides a method for the prevention of the incidence of and/or a reduction in the duration of acute diarrhoea, particularly in travelers, said method comprising orally administering an oligosaccharide composition, in particular a non-digestible oligosaccharide, to a mammal.
Abstract: A process for purifying a Streptococcus pyogenes GAS carbohydrate comprising a step of anionic exchange chromatography. The process provides a good yield of GAS carbohydrate. The saccharides of the invention have low levels of hyaluronic acid, protein and nucleic acid contamination.
Type:
Grant
Filed:
October 27, 2009
Date of Patent:
July 20, 2021
Assignee:
GLAXOSMITHKLINE BIOLOGICALS SA
Inventors:
Paolo Costantino, Francesco Berti, Anna Kabanova, Maria Rosaria Romano
Abstract: The present invention relates to artemisinic acid glycoconjugate compounds. More particularly, the present invention relates to a glycoconjugate compound of formula (I) and a process for the preparation of artemisinic acid glycoconjugate compound of formula (I) by using 1,3-dipolar cycloaddition chemistry starting from artemisinic acid.
Abstract: Objects of the present invention are to provide a phosphoric acid-esterified fine cellulose fiber of which slurry shows superior transparency, and to provide a method for producing a phosphorylated fine cellulose fiber showing superior transparency with good efficiency and high yield. According to the present invention, there is provided a phosphoric acid-esterified fine cellulose fiber, of which 0.2 mass % aqueous dispersion shows a solution haze of 15% or lower.
Abstract: The present invention relates to sulphated disaccharides of formula (I) for use in the treatment of neuropathic pain. The present invention also relates to a pharmaceutical composition comprising the compound of formula (I) and at least one pharmaceutically acceptable excipient for use in the treatment of neuropathic pain. The compounds of formula (I) were effective in several experimental models of neuropathic pain for which reason these compounds can be used effectively for the treatment of different types of neuropathic pain and the clinical manifestations thereof, for example, mechanical allodynia or cold allodynia.
Type:
Grant
Filed:
March 6, 2018
Date of Patent:
June 29, 2021
Assignees:
BIOBERICA, S.A.U., UNIVERSIDAD AUTONOMA DE MADRID, FUNDACION TEOFILO HERNANDO
Inventors:
Josep Vergés Milano, Eulàlia Montell Bonaventura, Ramon Ruhí Roura, Carlos Raúl Aláez Versón, Antonio García García, Manuela García López, Juan Fernando Padín Nogueira, Marcos Maroto Pérez, Javier Egea Máiquez
Abstract: The present invention provides a stable synthetic saccharide of Hib polyribosylribitol-phosphate (PRP) derivative and conjugate thereof. Said saccharide, said conjugate and pharmaceutical compositions thereof are hydrolysis-resistant, long-term stable and useful for the prevention and/or treatment of diseases associated with Haemophilus influenzae, and more specifically of diseases associated with Haemophilus influenzae type b, preferably diseases selected from meningitis, pneumonia, and epiglotitis. They have general formula (I): wherein A is formula (II) or formula (III); B is formula (IV); C is formula (V); D is formula (VI); E is formula (VII); F is formula (VIII) or formula (IX).
Type:
Grant
Filed:
July 28, 2017
Date of Patent:
May 25, 2021
Assignees:
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., Vaxxilon AG
Inventors:
Peter H. Seeberger, Claney Lebev Pereira
Abstract: Patients diagnosed with a cancer harboring an IDH-1 mutation can be treated by the administration of a therapeutically effective amount of a pharmaceutical composition comprising Compound 1, a selective inhibitor of 2-HG production from mIDH-1 enzymes including the R132 mutations R132C, R132H, R132L, R132G, and R132S.
Type:
Grant
Filed:
June 4, 2019
Date of Patent:
May 25, 2021
Assignee:
FORMA Therapeutics, Inc.
Inventors:
Susan Ashwell, Blythe Thomson, Patrick F. Kelly, Alan Collis, Jeff Davis, Duncan Walker, Wei Lu
Abstract: Provided herein is a conjugate comprising two residues of structurally and/or mechanistically different anticancer bioactive agents, coupled to one another by a biocleavable linking moiety, as well as methods of treating cancer using the same and pharmaceutical compositions comprising the same.
Type:
Grant
Filed:
June 13, 2017
Date of Patent:
May 18, 2021
Assignee:
Ariel Scientific Innovations Ltd.
Inventors:
Gary Gellerman, Yosi Gilad, Helena Tuchinsky
Abstract: The present invention refers to compounds of formula I or II endowed with DDX3 inhibitory activity, relative pharmaceutical compositions and their use as antihyperproliferative agents. (I) or (II).
Abstract: A composition for inhibiting a liver tumor in an organism is disclosed. The composition includes an activator being 1,2,3,4,6-penta-O-galloyl-Beta-D-glucopyranoside (PGG), wherein PGG is extracted from at least one of Paeonia lactiflora Pall. and Galla Chinesis.
Type:
Grant
Filed:
April 14, 2016
Date of Patent:
May 11, 2021
Assignee:
KAOHSIUNG MEDICAL UNIVERSITY
Inventors:
Yi-Ming Chen, Chia-Hung Yen, Chung-Kuang Lu
Abstract: A Pdia4 inhibitor for use in preventing, alleviating and/or treating diabetes and/or diabetes-related complications in a subject in need thereof is disclosed, wherein the Pdia4 inhibitor does not comprise cytopiloyene. A Pdia4 inhibitor and one other anti-diabetic agent for use in combination therapy in preventing, alleviating, treating diabetes and diabetes-related complications, and/or reversing diabetes in a subject in need thereof is also disclosed, wherein the Pdia4 inhibitors for use in combination therapy may comprise cytopiloyene. Also disclosed are methods for diagnosing, treating and monitoring diabetes, and methods of screening for a Pdia4 inhibitor and/or an anti-diabetic agent.
Abstract: A method for preparing ?-cellulose, a spinning composition, and a fiber material are provided. The method for preparing ?-cellulose includes providing a coffee residue; subjecting the coffee residue to a decolorization treatment, obtaining a white powder; reacting the white powder with an alkaline solution, obtaining a mixture; filtering the mixture to produce a filter cake; and baking the filter cake to obtain ?-cellulose.
Type:
Grant
Filed:
December 27, 2018
Date of Patent:
April 6, 2021
Assignee:
INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE